Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-23 Sale |
2023-02-27 5:46 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $7.8175 | $62,540 | 1,287,854 (Direct) |
View |
| 2023-02-24 Purchase |
2023-02-27 4:06 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
109,118 | $7.639 | $833,552 | 19,879,792 (Indirect) |
View |
| 2023-02-23 Purchase |
2023-02-24 4:08 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
51,864 | $7.7856 | $403,792 | 19,770,674 (Indirect) |
View |
| 2023-02-21 Sale |
2023-02-23 5:48 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $7.733 | $68,708 | 7,594,057 (Direct) |
View |
| 2023-02-22 Purchase |
2023-02-23 4:26 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
50,941 | $7.8329 | $399,016 | 19,718,810 (Indirect) |
View |
| 2023-02-21 Purchase |
2023-02-22 4:07 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
94,418 | $7.7435 | $731,126 | 19,667,869 (Indirect) |
View |
| 2023-02-17 Purchase |
2023-02-21 4:07 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
63,382 | $7.7149 | $488,986 | 19,573,451 (Indirect) |
View |
| 2023-02-16 Purchase |
2023-02-17 5:27 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
42,682 | $7.8966 | $337,043 | 19,510,069 (Indirect) |
View |
| 2023-02-15 Sale |
2023-02-17 5:13 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
9,254 | $8.3472 | $77,245 | 1,115,194 (Direct) |
View |
| 2023-02-14 Purchase |
2023-02-15 4:06 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
6,300 | $7.946 | $50,060 | 19,467,387 (Indirect) |
View |
| 2023-02-13 Purchase |
2023-02-14 4:10 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
32,474 | $7.9706 | $258,837 | 19,461,087 (Indirect) |
View |
| 2023-02-10 Purchase |
2023-02-13 4:41 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
11,000 | $7.9825 | $87,808 | 19,428,613 (Indirect) |
View |
| 2023-02-07 Sale |
2023-02-09 4:53 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $8.8084 | $78,263 | 7,602,942 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-03 5:11 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $9.2172 | $193,561 | 10,793,618 (Indirect Direct) |
View |
| 2023-02-01 Purchase |
2023-02-02 4:07 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
600 | $7.97 | $4,782 | 19,417,613 (Indirect) |
View |
| 2023-01-26 Sale |
2023-01-27 5:03 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $8.0684 | $64,547 | 1,071,664 (Direct) |
View |
| 2023-01-26 Purchase |
2023-01-27 4:27 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
7,886 | $7.9896 | $63,006 | 19,417,013 (Indirect) |
View |
| 2023-01-24 Sale |
2023-01-26 6:04 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $8.7077 | $77,368 | 7,611,827 (Direct) |
View |
| 2023-01-25 Purchase |
2023-01-26 4:11 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
24,526 | $7.8801 | $193,267 | 19,409,127 (Indirect) |
View |
| 2023-01-17 Sale |
2023-01-19 5:01 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
10,000 | $9.1561 | $91,561 | 796,001 (Direct) |
View |
| 2022-12-23 Purchase |
2023-01-13 4:19 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
1,029,795 | $7.5023 | $7,725,857 | 19,384,601 (Indirect) |
View |
| 2023-01-10 Sale |
2023-01-12 5:46 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $7.6852 | $68,283 | 7,620,712 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-06 6:28 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $7.3872 | $155,131 | 9,584,550 (Indirect Direct) |
View |
| 2022-12-29 Sale |
2022-12-30 5:01 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $7.6958 | $61,566 | 1,079,664 (Direct) |
View |
| 2022-12-27 Sale |
2022-12-29 5:39 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $7.2451 | $64,373 | 7,628,272 (Direct) |
View |
| 2022-12-15 Sale |
2022-12-19 5:32 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
10,000 | $8.8525 | $88,525 | 806,001 (Direct) |
View |
| 2022-12-13 Sale |
2022-12-15 5:26 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $8.9587 | $79,598 | 7,637,157 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-02 6:17 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,710 | $9.0392 | $358,947 | 9,662,550 (Indirect Direct) |
View |
| 2022-11-29 Sale |
2022-12-01 5:14 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
8,885 | $8.7547 | $77,786 | 7,646,042 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-23 Exercise |
2023-02-27 5:46 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $0 | 1,287,854 (Direct) |
View |
| 2023-02-23 Exercise |
2023-02-27 5:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $1.06 | 1,287,854 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 5:16 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
1,603 | $8.44 | 427,844 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 5:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
1,258 | $8.44 | 794,310 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 5:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,346 | $8.44 | 940,927 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 5:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
746 | $8.44 | 1,115,194 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 5:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
7,486 | $2.22 | 1,115,194 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 5:13 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
7,486 | $0 | 1,115,194 (Direct) |
View |
| 2023-02-01 Tax Withholding |
2023-02-03 5:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
2,669 | $8.55 | 1,200,425 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:14 pm |
N/A 2033-02-01 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
615,020 | $0 | 1,200,425 (Direct) |
View |
| 2023-02-01 Tax Withholding |
2023-02-03 5:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
3,093 | $8.55 | 1,731,579 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:13 pm |
N/A 2033-02-01 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
660,915 | $0 | 1,731,579 (Direct) |
View |
| 2023-02-01 Tax Withholding |
2023-02-03 5:12 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
2,994 | $8.55 | 1,125,194 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:12 pm |
N/A 2033-02-01 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
329,597 | $0 | 1,125,194 (Direct) |
View |
| 2023-02-02 Conversion |
2023-02-03 5:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,793,618 (Direct) |
View |
| 2023-02-01 Tax Withholding |
2023-02-03 5:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,382 | $8.55 | 10,793,618 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:11 pm |
N/A 2033-02-01 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,231,450 | $0 | 10,793,618 (Direct) |
View |
| 2023-01-26 Exercise |
2023-01-27 5:03 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $0 | 1,071,664 (Direct) |
View |
| 2023-01-26 Exercise |
2023-01-27 5:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $1.06 | 1,071,664 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 5:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
5,000 | $2.22 | 796,001 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 5:01 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
5,000 | $0 | 796,001 (Direct) |
View |
| 2023-01-05 Conversion |
2023-01-06 6:28 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,584,550 (Direct) |
View |
| 2022-04-25 Gift |
2023-01-06 6:28 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
57,000 | $0 | 9,584,550 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:29 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,573 | $0 | 3,808,733 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:28 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
1,325 | $0 | 7,629,597 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
1,407 | $0 | 13,625,620 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,821 | $0 | 159,235 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:23 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
2,483 | $0 | 35,684 (Direct) |
View |
| 2022-12-29 Exercise |
2022-12-30 5:01 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $0 | 1,079,664 (Direct) |
View |
| 2022-12-29 Exercise |
2022-12-30 5:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
8,000 | $1.06 | 1,079,664 (Direct) |
View |
| 2022-12-15 Exercise |
2022-12-19 5:32 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
5,000 | $2.22 | 806,001 (Direct) |
View |
| 2022-12-15 Exercise |
2022-12-19 5:32 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
5,000 | $0 | 806,001 (Direct) |
View |
| 2022-12-01 Conversion |
2022-12-02 6:17 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,662,550 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 6:17 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,662,550 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 6:17 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,662,550 (Direct) |
View |